221 related articles for article (PubMed ID: 17203518)
1. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C.
Takeda T; Yasuda T; Nakayama Y; Nakaya M; Kimura M; Yamashita M; Sawada A; Abo K; Takeda S; Sakaguchi H; Shiomi S; Asai H; Seki S
World J Gastroenterol; 2006 Dec; 12(48):7768-73. PubMed ID: 17203518
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography.
Tatsumi C; Kudo M; Ueshima K; Kitai S; Takahashi S; Inoue T; Minami Y; Chung H; Maekawa K; Fujimoto K; Akiko T; Takeshi M
Intervirology; 2008; 51 Suppl 1():27-33. PubMed ID: 18544945
[TBL] [Abstract][Full Text] [Related]
3. Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon.
Kojima H; Hongo Y; Harada H; Inoue T; Miyaji K; Kashiwagi M; Momose T; Arisaka Y; Fukui H; Murai S; Tokita H; Kamitsukasa H; Yagura M; Katsu K
J Gastroenterol Hepatol; 2001 Sep; 16(9):1015-21. PubMed ID: 11595066
[TBL] [Abstract][Full Text] [Related]
4. Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C.
Andersen ES; Moessner BK; Christensen PB; Kjær M; Krarup H; Lillevang S; Weis N
Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):41-4. PubMed ID: 21079513
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.
Saitou Y; Shiraki K; Yamanaka Y; Yamaguchi Y; Kawakita T; Yamamoto N; Sugimoto K; Murata K; Nakano T
World J Gastroenterol; 2005 Jan; 11(4):476-81. PubMed ID: 15641129
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
[TBL] [Abstract][Full Text] [Related]
7. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation.
Harada N; Soejima Y; Taketomi A; Yoshizumi T; Ikegami T; Yamashita Y; Itoh S; Kuroda Y; Maehara Y
Transplantation; 2008 Jan; 85(1):69-74. PubMed ID: 18192914
[TBL] [Abstract][Full Text] [Related]
8. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
9. Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
Yagura M; Murai S; Kojima H; Tokita H; Kamitsukasa H; Harada H
J Gastroenterol; 2000; 35(2):105-11. PubMed ID: 10680665
[TBL] [Abstract][Full Text] [Related]
10. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system.
Ninomiya T; Yoon S; Hayashi Y; Sugano M; Kumon Y; Seo Y; Shimizu K; Kasuga M
J Gastroenterol Hepatol; 1998 Jan; 13(1):68-74. PubMed ID: 9737575
[TBL] [Abstract][Full Text] [Related]
13. Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients With Chronic Hepatitis C After Viral Eradication.
Chen SH; Lai HC; Chiang IP; Su WP; Lin CH; Kao JT; Chuang PH; Hsu WF; Wang HW; Chen HY; Huang GT; Peng CY
Clin Infect Dis; 2020 Jan; 70(1):114-122. PubMed ID: 30816416
[TBL] [Abstract][Full Text] [Related]
14. Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan.
Wang JH; Changchien CS; Hung CH; Tung WC; Kee KM; Chen CH; Hu TH; Lee CM; Lu SN
J Gastroenterol Hepatol; 2010 May; 25(5):964-9. PubMed ID: 20546451
[TBL] [Abstract][Full Text] [Related]
15. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
16. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
17. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients.
Omran D; Yosry A; Darweesh SK; Nabeel MM; El-Beshlawey M; Saif S; Fared A; Hassany M; Zayed RA
Clin Exp Med; 2018 Feb; 18(1):45-50. PubMed ID: 28567544
[TBL] [Abstract][Full Text] [Related]
18. Serum hyaluronan as a marker of liver fibrosis in hemophiliacs with hepatitis C virus-associated chronic liver disease.
Yamada M; Fukuda Y; Nakano I; Katano Y; Takamatsu J; Hayakawa T
Acta Haematol; 1998; 99(4):212-6. PubMed ID: 9644299
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.
D'Ambrosio R; Aghemo A; Fraquelli M; Rumi MG; Donato MF; Paradis V; Bedossa P; Colombo M
J Hepatol; 2013 Aug; 59(2):251-6. PubMed ID: 23528378
[TBL] [Abstract][Full Text] [Related]
20. Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
Jia J; Hou J; Ding H; Chen G; Xie Q; Wang Y; Zeng M; Zhao J; Wang T; Hu X; Schuppan D
J Gastroenterol Hepatol; 2015 Apr; 30(4):756-62. PubMed ID: 25353058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
